No Data
UBS Group: Assigns a "Neutral" rating to the Hong Kong Stock Exchange, lowering the Target Price to 306 Hong Kong dollars.
UBS Group released a research report stating that it gives Hong Kong Exchanges and Clearing (00388) a "neutral" rating. As for the ADT forecast for the next two years, it has been lowered from 146 billion and 162 billion yuan to 121 billion and 133 billion yuan to reflect the expected lower index returns this year. Correspondingly, the earnings per share forecast has also been reduced by 10% and 9%, with the Target Price being lowered from 346 HKD to 306 HKD. The bank predicts that the pure profit of Hong Kong Exchanges and Clearing will increase by 50% year-on-year in the fourth quarter of last year to 3.9 billion yuan, which is 5% higher than the market's general expectations, mainly due to possibly higher-than-expected net investment income and a decrease in the effective tax rate; at the same time, it forecasts that quarterly revenue will increase year-on-year.
PA GOODDOCTOR received a full purchase offer from the controlling Shareholder, Anxin.
PA GOODDOCTOR (01833) and the offeror Anxin Co., Ltd. jointly announced that based on the stock dividend plan and the choices made under it, a total of 1,042,630,820 new shares will be distributed and issued as special dividends. It is expected that the formal stocks of these new shares will be mailed on January 24, 2025, and they will start trading on the Hong Kong Stock Exchange at 9:00 AM (Hong Kong time) on January 27, 2025. Among these new shares, 698,970,587 new shares will be distributed and issued to the offeror. New shares related to the distribution and issuance as special dividends under the stock dividend plan.
UBS Declares Coupon Payments on 12 ETRACS Exchange Traded Notes
Financial Advisor Michael Rubenstein Joins UBS Private Wealth Management
Sector Update: Financial Stocks Advance Pre-Bell Monday
Sector Update: Financial
loading...
Buy n Die Together❤ :
Sunny Soh OP : Watch here: https://youtu.be/jYIV-2f-VP0